Press releases
- GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancers at ASCO Gastrointestinal Cancers Symposium
- Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
- Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19
Tweets from GSK US
-
GSKUS @GSKUS
#HCPs: Do your 50+ patients know that they are at risk of developing #shingles, even if they are healthy and active? Find resources to share with your patients on our #ShinglesDoesntPlayFavorites page: 👉gsk.to/3qt44tpd
about 1 hour ago
Jj
-
GSKUS @GSKUS
On this national #MLKDayofService, our colleagues will part take in virtual volunteering projects across the country. What will you do to give back today?
about 1 day ago
-
GSKUS @GSKUS
Today, we honor and celebrate the life and accomplishments of Dr. Martin Luther King Jr. When we don’t look and act the same, it makes for a deeply rich and rewarding human experience. Diversity makes us stronger.
about 1 day ago
